技術開発企業向け医療市場（米国の電子カルテ、バーチャルリアリティ、ワイヤレス技術、RFID、および医療機器部品アウトソーシング）

Abstract

There is over a 30 billion dollar market for technology companies who assist the healthcare industry meet its challenges. This report is a combination of 5 Kalorama Information Market research reports - over 1100 pages of material. This report details the 5 areas Kalorama thinks will be the most promising markets for technology in healthcare.

• Wireless Technologies: Perfectly suited for the mobile employees of healthcare, wireless technologies are expect to show promising growth. This report details the market going forward to 2010. Includes Bluetooth, WLAN, Zigbee, WPAN and other technologies. Case studies and cost saving scenarios are included.
• EMR (Electronic Medical Records): U.S. privacy regulations will drive healthcare systems and hospitals to turn to EMR vendors. Any vendor seeking to sell into hospitals or physicians offices will need to give thought to the market and competition for electronic medical records.
• RFID in Healthcare in the U.S.: Inventory control is essential to an industry that deals with highly valuable, highly regulated, yet highly scattered assets. This report details both the markets for this technology, the key sectors of demand, and cost saving projections.
• Medical Device Outsourcing - Electronic Components and Advanced Systems: Increasingly device companies are unable to meet demand in-house. Companies who have not considered medical markets may find a willing customer for their services in the med device area.
• Virtual Reality Applications in Healthcare: No longer a technology for games or science fiction, Virtual Reality or VR has real applications in healthcare, especially in education, surgery and 3D visualization of medical scenarios

Table of Contents

TECHNOLOGY AREA: EMR Technolgies in Healthcare

chapter 1: Executive Summary

• 1.1 Healthcare Industry
• 1.2 Information Technology (IT) in Healthcare
• 1.3 Definition and Scope of Study
• 1.4 EMR in Healthcare
• 1.5 Key EMR Technologies
• 1.6 Emerging Technologies and Application Areas
• 1.7 Market Overview
• 1.8 Competitive Landscape
• 1.9 End-user Analysis
• 1.10 Regulatory Environment
• 1.11 Conclusions and Future Outlook

chapter 2: Introduction

• 2.1 Healthcare Industry
  • 2.1.1 Overview
  • 2.1.2 Structure of the Healthcare Industry
  • 2.1.3 Trends
  • 2.1.4 Challenges
  • 2.1.5 Market Size

• 2.2 Information Technology (IT) in Healthcare
  • 2.2.1 Overview
  • 2.2.2 Market Size
  • 2.2.3 Conclusions - The US vs. Europe

• 2.3 Definition and Scope of Study

chapter 3: Medical Records (EMR)

• 3.1 Medical Records
  • 3.1.1 Introduction
  • 3.1.2 Current Practices
  • 3.1.3 Transition to Computerization

• 3.2 Introduction to EMR
  • 3.2.1 Definition
  • 3.2.2 Terminologies Used in the Industry

• 3.3 Functional Requirements of EMR
  • 3.3.1 Basic Functionalities
  • 3.3.2 Additional Functionalities

• 3.4 Advantages of EMR
• 3.5 Limitations of EMR
• 3.6 Key EMR Technologies
  • 3.6.1 Software Requirements
  • 3.6.2 Hardware Requirements

• 3.7 Components of an EMR
  • 3.7.1 Overview
  • 3.7.2 Major Components of EMRs

• 3.8 Emerging Trends
  • 3.8.1 Emerging Technologies
  • 3.8.2 Emerging EMR Application Areas

chapter 4: MARKET Overview

• 4.1 Market Definition
• 4.2 Market Size
• 4.3 Market Adoption
  • 4.3.1 The EMR Adoption Model
  • 4.3.2 Adoption Scenario
  • 4.3.3 Projected Benefits of EMR Adoption

• 4.4 Drivers and Inhibitors
  • 4.4.1 EMR Adoption - Drivers
  • 4.4.2 EMR Adoption - Inhibitors

• 4.5 Implementation Costs and Return on Investments (ROI)
  • 4.5.1 Implementation Costs and ROI for Office-based Physicians
  • 4.5.2 Implementation Costs and ROI for Hospitals
  • 4.5.3 Summary

• 4.6 Competitive Landscape
  • 4.6.1 Market Segmentation
  • 4.6.2 Market Shares of EMR Vendors
  • 4.6.3 Mergers and Acquisitions (M&As)
  • 4.6.4 Pricing of EMR Solutions
  • 4.6.5 Purchasing, Marketing, and Distributing EMR Products

chapter 5: DEMAND Side Analysis

• 5.1 Introduction
• 5.2 Office-based Physicians
  • 5.2.1 Overview
  • 5.2.2 Case Study

• 5.3 Hospitals
  • 5.3.1 Overview
  • 5.3.2 Case Study

• 5.4 Pharmacies
  • 5.4.1 Overview
  • 5.4.2 Pharmaceutical Industry Initiatives
  • 5.4.3 Case Study

• 5.5 Health Insurance Providers
  • 5.5.1 Overview
  • 5.5.2 Initiatives of the Department of Health and Human Services

• 5.6 Consumer Preferences and Future Plans
  • 5.6.1 IT Preferences
  • 5.6.2 IT Application Preferences
  • 5.6.3 Technology Adoption Preferences
  • 5.6.4 IT Operating Budget of Healthcare Facilities

chapter 6: Key Regulations and Certifications

• 6.1 Introduction
• 6.2 Need For Regulation
• 6.3 History and Background for Regulations
• 6.4 Introduction to HIPAA
  • 6.4.1 Privacy Rule
  • 6.4.2 Security Rule
  • 6.4.3 Limitations
  • 6.4.4 HIPAA Penalties

• 6.5 Code of Federal Regulations (CFR) - Part 11
• 6.6 Key Certifications
  • 6.6.1 The Certification Commission for Healthcare Information Technology

• 6.7 Conclusions

chapter 7: Conclusions

• 7.1 First Conclusion: EMR a Necessity
• 7.2 Second Conclusion: US is Market Leader
• 7.3 Third Conclusion: Office-Based Physicians are the Growth Area
• 7.4 Fourth Conclusion: EMR Costs Will Be Reduced
• 7.5 Fifth Conclusion: EMR Software is Defined By Applications
• 7.6 Sixth Conclusion: There is a Large Market For Vendors
• 7.7 Seventh Conclusion: EMR is a Budget Priority For Healthcare Companies
• 7.8 Eighth Conclusion: HIPPA to Drive EMR Growth

chapter 8: Company Profiles

• 8.1 Cerner Corporation
  • 8.1.1 Key Facts
  • 8.1.2 Company Overview
  • 8.1.3 Corporate Partnerships
  • 8.1.4 Geographical Presence and Business Lines
  • 8.1.5 Product Portfolio
  • 8.1.6 Staff Organization
  • 8.1.7 Key Executives
  • 8.1.8 Key Competitors
  • 8.1.9 Performance Review
  • 8.1.10 Company Strategy

• 8.2 COMPUTER PROGRAMS AND SYSTEMS, INC. (CPSI)
  • 8.2.1 Key Facts
  • 8.2.2 Company Overview
  • 8.2.3 Product Portfolio
  • 8.2.4 Staff Organization
  • 8.2.6 Key Competitors
  • 8.2.7 Performance Review

• 8.3 Eclipsys Corporation
  • 8.3.1 Key Facts
  • 8.3.2 Company Overview
  • 8.3.3 Corporate Partnerships
  • 8.3.4 Geographical Presence and Business Lines
  • 8.3.5 Product Portfolio
  • 8.3.6 Organization of Business
  • 8.3.7 Key Executives
  • 8.3.8 Key Competitors
  • 8.3.9 Performance Review
  • 8.3.10 Company Strategy

• 8.4 Epic Systems Corporation
  • 8.4.1 Key Facts
  • 8.4.2 Company Overview
  • 8.4.3 Corporate Partnerships
  • 8.4.4 Product Portfolio
  • 8.4.5 Key Executives
  • 8.4.6 Key Competitors

• 8.5 GE Healthcare
  • 8.5.1 Key Facts
  • 8.5.2 Company Overview
  • 8.5.3 Geographical Presence and Business Lines
  • 8.5.4 Product Portfolio
  • 8.5.5 Key Executives
  • 8.5.6 Key Competitors
  • 8.5.7 Performance Review

• 8.6 McKesson Corporation
  • 8.6.1 Key Facts
  • 8.6.2 Company Overview
  • 8.6.3 Corporate Partnerships
  • 8.6.4 Geographical Presence and Business Lines
  • 8.6.5 Product Portfolio
  • 8.6.6 Organization of Businesses
  • 8.6.7 Key Executives
  • 8.6.8 Key Competitors
  • 8.6.9 Performance Review
  • 8.6.10 Company Strategy

• 8.7 Medical Information Technology, Inc. (MEDITECH)
  • 8.7.1 Key Facts
  • 8.7.2 Company Overview
  • 8.7.3 Corporate Partnerships
  • 8.7.4 Geographic Presence and Business Lines
  • 8.7.5 Product Portfolio
  • 8.7.6 Staff Organization
  • 8.7.7 Key Executives
  • 8.7.8 Key Competitors
  • 8.7.9 Performance Review

• 8.8 MedPlus
  • 8.8.1 Key Facts
  • 8.8.2 Company Overview
  • 8.8.3 Corporate Partnerships
  • 8.8.4 Business Lines & Product Portfolio
  • 8.8.5 Key Competitors
  • 8.8.6 Key Executives

• 8.9 Quadramed Corporation
  • 8.9.1 Key Facts
  • 8.9.2 Company Overview
  • 8.9.3 Geographical Presence and Business Lines
  • 8.9.4 Product Portfolio
  • 8.9.5 Staff Organization
  • 8.9.6 Key Executives
  • 8.9.7 Key Competitors
  • 8.9.8 Performance Review

• 8.10 Siemens Medical Solutions
  • 8.10.1 Key Facts
  • 8.10.2 Company Overview
  • 8.10.3 Geographical Presence and Business Lines
  • 8.10.4 Product Portfolio
  • 8.10.5 Key Executives
  • 8.10.6 Key Competitors
  • 8.10.7 Performance Review

LIST OF EXHIBITS

chapter 1: executive summary

• Figure 1-1: Market Size for EMR in the US (2003-2015)
• Table 1-1: Total Implementation Cost for Healthcare systems (US, 2005)

chapter 2: introduction

• Figure 2-1: Value Chain of the Healthcare Industry
• Figure 2-2: Sector-wise Contribution to the US GDP (2005)
• Figure 2-3: The US Healthcare Spending (2003-2013)
• Figure 2-4: Government HealthCare Spending as a Share of GDP (2005)
• Figure 2-5: European Union Spending on HIT (2005-2009)
• Figure 2-6: Pacific Spending on HIT (2004-2009)
• Figure 2-7: US Spending on HIT (2002-2008)

chapter 3: electronic medical records

• Table 3-1: Typical Contents of a Medical Record
• Figure 3-1: Key Components of an EMR
• Figure 3-2: Patient Data Flow across the Key Components of an EMR (I)
• Figure 3-3: Patient Data Flow across the Key Components of an EMR (II)
• Figure 3-4: Commercialization Chain for a New Technology
• Figure 3-5: EMR Access through Individualized Smart Cards
• Table 3-5: Hypothetical Monthly Distribution of the Number of Vaccines Administered
• Figure 3-65: Hypothetical Monthly Distribution of the Number of Vaccines Administered

chapter 4: market overview

• Figure 4-1: Categorization of the Healthcare Information Technology Domain
• Figure 4-2: Market Size for EMR in the US (2003-2015)
• Table 4-1: Stages of EMR Adoption
• Table 4-2: Adoption of EMR, CPOE, and Radiology PACS (US, 2005)
• Figure 4-3: Adoption of EMR in Combination with Various Clinical Tools
• Figure 4-4: Adoption of EMR, CPOE, PACS across Different Types of Healthcare Systems (US, 2005)
• Table 4-3: Cost Break-up for a Typical One-physician Practice (5-year period)
• Figure 4-5: Year-wise Distribution of Cumulative Savings
• Table 4-4: Total Implementation Cost for Healthcare Systems
• Figure 4-6: Market Segmentation Based on Vendor' s Business Strategies
• Table 4-5: Market Share of Top 10 EMR Vendors (2004-2005)
• Table 4-6: Mergers and Acquisitions (1999-2005)
• Table 4-7: Average Total Cost for a Three-physician Practice for EMR/PMS Installations (2005-2008)
• Table 4-8: Total Cost Range for EMR/PMS Installations (2005)
• Figure 4 -7: Average Costs for a Typical Three-physician Practice (2005)
• Table 4-9: Two-year Total Cost for EMR/PMS Installations/Subscriptions
• Figure 4-8: Purchasing Process Sequence and Responsible Entities

chapter 5: demand side analysis

• Table 5-1: Age-wise Percentage Distribution of Office-based Physicians Using EMR (US, 2005)
• Table 5-2: Percentage Distribution of Office-based Physicians Using EMR by Practice Characteristics (US, 2005)
• Table 5-3: Location Characteristics of Office-based Physicians 2005 (US, 2005)
• Table 5-4: Percentage of Office-based Physicians Using Select EMR Features (US, 2005)
• Figure 5-1: Areas where Benefits have been Achieved Post-EMR Implementation
• Figure 5-2: North Fulton Practice Time Savings (2000)
• Figure 5-3: North Fulton Practice Cost Savings (2000)
• Table 5-5: Percentage Installation of Various Clinical Applications in Hospitals (US, 2004)
• Table 5-6 : Hospitals Automated or Contracted for EMR, CDR, CPOE, LIS, PMS, POC, RIS, and Radiology PACS (US, 2004)
• Table 5-7: EMR System Implementation Rate across Various Operating Room Environments (US, 2005)
• Table 5-8: Percentage of Hospital Emergency and Outpatient Departments Using EMR Systems (US, 2002)
• Table 5-9: Adoption of CPOE Applications and Functions by Pharmacies (US, 2006-2010)
• Table 5-10: Adoption of e-Prescribing Applications by Commercial/Retail Pharmacies (US, 2006-2010)
• Table 5-11: EMR, CPOE, PACS Adoption by Hospitals with a Majority or Minority of Medicare Patients (US, 2005)
• Table 5-12 : EMR, CPOE, PACS Adoption by Hospitals with a Majority or Minority of Medicaid Patients (US, 2005)
• Figure 5-4: IT Priorities of Healthcare Organizations in the US (2005-2008)
• Figure 5-5: IT Application Preferences of Healthcare Organizations in the US for the Next Two Years (2005 vs. 2006)
• Figure 5-6: Status of EMR Implementation in Healthcare Organizations in the US (2004-2006)
• Figure 5-7: Technology Adoption Preferences of Healthcare Organizations in the US (2005-2006)
• Figure 5-8: Outlook of Technology Adoption for the Next Two Years (2005 vs. 2006)
• Figure 5-9: Estimated Change in the IT Operating Budget (2006-2007)

chapter 6: key regulations and certifications

• Figure 6-1: Formation of Regulations
• Table 6-1: Vendors and their CCHIT Certified Products

chapter 8: company profiles

• Table 8-1: Corporate Details of Cerner Corporation
• Table 8-2: Geographical Presence and Business Lines of Cerner Corporation
• Table 8-3: Key Executives of Cerner Corporation
• Figure 8-1: Cerner Sales Performance, Geography-wise (2005)
• Figure 8-2: Cerner Revenue Performance (2001-2005)
• Figure 8- 3: Breakup Revenue by Service Type (Percentage)
• Table 8-4: Corporate Details of CPSI
• Table 8-5: Key Executives of CPSI
• Figure 8-4: CPSI Hospital Clients (2001-2005)
• Figure 8-5: CPSI Revenue Performance (2001-2005)
• Figure 8-6: Category-wise Revenue Performance of CPSI (2005)
• Table 8-6: Corporate Details of Eclipsys Corporation
• Table 8-7: Eclipsys Corporation' s Business Relationships
• Table 8-8: Geographical Presence of Eclipsys Corporation
• Table 8-9: Key Executives of Eclipsys
• Figure 8-7: Eclipsys Sales Performance 2005 (by geography)
• Figure 8-8: Eclipsys Revenue Performance (2001-2005)
• Table 8-10: Corporate Details of EPIC
• Table 8-11: Corporate Partnerships of Epic Corporation
• Table 8-12: Key Executives of EPIC SYSTEMS
• Table 8-13: Corporate Details of GE HEALTHCARE
• Table 8 - 14: Geographical Presence of GE Healthcare
• Table 8-15: GE Healthcare Key Executives
• Figure 8-9: GE Healthcare Revenue Performance (2001-2005)
• Table 8-16: Corporate Details of McKesson Corporation
• Table 8-17: Corporate Partners of McKesson Corporation
• Table 8-18: Geographical Presence and Business Lines; McKesson Corporation
• Figure 8-10: Business Divisions McKesson Corporation
• Table 8-19: Key McKesson Corporation Executives
• Figure 8-11: Breakup of Revenue Business Segment-wise (Percentage)
• Figure 8-12:Breakup of Revenue Geography-wise (Percentage)
• Figure 8-13: McKesson Revenue Performance (2002-2006)
• Table 8-20: Corporate Details of MEDITECH
• Table 8-21: Geographical Presence of MEDITECH
• Table 8-22: Software Services Provided by MEDITECH
• Table 8-22: Software Services Provided by MEDITECH
• Table 8-23: Key Executives of MEDITECH.
• Table 8-24: Key Competitors of MEDITECH
• Figure 8-14: MEDITECH Sales Performance by geography (2002)
• Figure 8-15: MEDITECH Sales Performance by Geography (2003)
• Table 8-25: MEDITECH Sales Performance (by category)
• Figure 8-16: MEDITECH Revenue Performance (2001-2005)
• Table 8-26: Corporate Details of MEDPLUS
• Table 8-27: MEDPLUS Corporation' s Business Relationships
• Table 8-28: Key Executives of MEDPLUS
• Table 8-29: Corporate Details of QUADRAMED
• Table 8-30: Geographical Presence and Business Lines of QUADRAMED CORPORATION
• Table 8-31: Key Executives of QUADRAMED
• Figure 8.17: QUADRAMED Revenue Performance (2001-2005)
• Table 8-32: Corporate Details of Siemens Medical Solutions
• Table 8-33: Geographical Presence of Siemens Medical Solutions
• Table 8-34: Key Executives of Siemens Medical Solutions

TECHNOLOGY AREA: Wireless Technologies

chapter One: Executive Summary

• 1.1 Healthcare Industry
• 1.2 Wireless Industry
• 1.3 Wireless in Healthcare
• 1.4 Definition and Scope of Study
• 1.5 Application of Wireless Technologies in Healthcare
  • 1.5.1 Emerging Applications
• 1.6 Key Wireless Technologies
• 1.7 Implementing Wireless Technologies in Healthcare
• 1.8 Market Overview
  • 1.8.1 Market for Wireless Technologies in Healthcare
  • 1.8.2 Competitive Landscape
• 1.9 Consumer Analysis
• 1.10 Regulatory Environment
• 1.11 Conclusions and Future Outlook

chapter Two: Overview

• 2.1 Healthcare Industry
  • 2.1.1 Worldwide Healthcare Market
    • 2.1.1.1 Information Technology (IT) Market in Healthcare
  • 2.1.2 Trends
  • 2.1.3 Challenges

• 2.2 Wireless Industry
  • 2.2.1 Worldwide Wireless Market
  • 2.2.2 Trends
  • 2.2.3 Challenges

• 2.3 Wireless in Healthcare
  • 2.3.1 US - The Best Market for Wireless Technologies in Healthcare
  • 2.3.2 Trends
  • 2.3.3 Challenges

• 2.4 Definition and Scope of Study

chapter Three: Opportunities for Wireless Applications in Healthcare

• 3.1 Introduction
  • 3.1.1 Key Benefits
• 3.2 Healthcare Industry Segmentation for Wireless Applications
  • 3.2.1 Healthcare Service Providers
    • 3.2.1.1 Applications of Wireless Technologies for Healthcare Service Providers Segment
  • 3.2.2 Pharmaceuticals
    • 3.2.2.1 Application of Wireless Technologies for the Pharmaceuticals Segment
  • 3.2.3 Health Plan Providers
    • 3.2.3.1 Applications of Wireless Technologies for Health Plan Providers Segment

• 3.3 Key Applications
  • 3.3.1 Remote Patient Monitoring
    • 3.3.1.1 Market Overview
  • 3.3.2 Clinical Drug Trials
    • 3.3.2.1 Market Overview
  • 3.3.3 E-Prescription
    • 3.3.3.1 Market Overview
  • 3.3.4 Patient/Asset Tracking
    • 3.3.4.1 Market Overview
  • 3.3.5 Pharmaceutical Sales Force
    • 3.3.5.1 Market Overview

chapter Four: Key Wireless Technologies

• 4.1 Data Transmission Sessions
• 4.2 Wireless Operating Systems, Languages, and Protocols
• 4.3 Wireless Networking Technologies
  • 4.3.1 Wireless Personal Area Network - Bluetooth
    • 4.3.1.1 Market Overview
    • 4.3.1.2 Benefits of Bluetooth in Healthcare
    • 4.3.1.3 Applications of Bluetooth in Healthcare
    • 4.3.1.4 Issues with Bluetooth Adoption in Healthcare
  • 4.3.2 Wireless Personal Area Network - RFID
    • 4.3.2.1 Market Overview
    • 4.3.2.2 Benefits of RFID in Healthcare
    • 4.3.2.3 Applications of RFID in Healthcare
    • 4.3.2.4 Issues with RFID Adoption in Healthcare
  • 4.3.3 Wireless Personal Area Network - Zigbee
    • 4.3.3.1 Market Overview
    • 4.3.3.2 Benefits of Zigbee in Healthcare
    • 4.3.3.3 Applications of Zigbee in Healthcare
    • 4.3.3.4 Issues with Zigbee Adoption in Healthcare
  • 4.3.4 Wireless Personal Area Network - UWB
    • 4.3.4.1 Market Overview
    • 4.3.4.2 Benefits of UWB in Healthcare
    • 4.3.4.3 Applications of UWB in Healthcare
  • 4.3.5 Wireless Local Area Network (WLAN)
    • 4.3.5.1 Market Overview
    • 4.3.5.2 Benefits of WLAN in Healthcare
    • 4.3.5.3 Applications of WLAN in Healthcare
    • 4.3.5.4 Issues with WLAN Adoption in Healthcare
  • 4.3.6 Wireless Metropolitan Area Network (WMAN)
    • 4.3.6.1 Market Overview
    • 4.3.6.2 Benefits of WMAN in Healthcare
    • 4.3.6.3 Applications of WMAN in Healthcare
    • 4.3.6.4 Issues with WMAN Adoption in Healthcare
  • 4.3.7 Wireless Wide Area Network (WWAN)
    • 4.3.7.1 Market Overview
    • 4.3.7.2 Benefits of WWAN in Healthcare
    • 4.3.7.3 Applications of WWAN in Healthcare
    • 4.3.7.4 Issues with WWAN Adoption in Healthcare

chapter Five: Implementing Wireless Technologies in Healthcare

• 5.1 Wireless Infrastructure for Healthcare
• 5.2 Planning for Wireless Infrastructure Deployment
• 5.3 Initiation and Execution of a Wireless Deployment Project
• 5.4 Cost of Implementation of Infrastructure
  • 5.4.1 Cases of Wireless Implementation Costs
  • 5.4.2 Return-on-Investment Period

chapter Six: Market Overview of Wireless Technologies in Healthcare

• 6.1 Market Definition
• 6.2 Market Size
  • 6.2.1 The US Wireless Market in Healthcare
    • 6.2.1.1 Technology-wise Market Break-up
  • 6.2.2 WPAN - Bluetooth Market in Healthcare
  • 6.2.3 WPAN - RFID Market in Healthcare
  • 6.2.4 WPAN - Zigbee Market in Healthcare
  • 6.2.5 WPAN - UWB Market in Healthcare
  • 6.2.6 WLAN Market in Healthcare
  • 6.2.7 WMAN Market in Healthcare
  • 6.2.8 WWAN Market in Healthcare

• 6.3 Technology Adoption
• 6.4 Competitive Landscape
  • 6.4.1 Segmentation of Players
    • 6.4.1.1 Network Infrastructure Providers
    • 6.4.1.2 Software Providers
    • 6.4.1.3 Medical Device Manufacturers
  • 6.4.2 Market Shares
  • 6.4.3 Distribution Channel

• 6.5 Drivers and Inhibitors
  • 6.5.1 Growth Drivers
  • 6.5.2 Growth Inhibitors

• 6.6 Emerging Trends
  • 6.6.1 Emerging Applications
    • 6.6.1.1 Nanobots
    • 6.6.1.2 Implantable Medical Devices

chapter Seven: Demand Side Analysis

• 7.1 Consumer Statistics
  • 7.1.1 Hospitals
    • 7.1.1.1 Number of Hospitals
    • 7.1.1.2 Technology Adoption in Hospitals
    • 7.1.1.3 The Most Wireless Hospitals
  • 7.1.2 Physicians
    • 7.1.2.1 Number of Physicians
    • 7.1.2.2 Technology Adoption by Physicians
  • 7.1.3 Nursing Homes
    • 7.1.3.1 Technology Adoption by Nursing Homes
  • 7.1.4 Pharmacies
    • 7.1.4.1 Technology Adoption by Pharmacies
  • 7.1.5 Medical and Diagnostic Laboratories
    • 7.1.5.1 Technology Adoption by Laboratories
  • 7.1.5 Life Insurance Carriers
    • 7.1.5.1 Technology Adoption by Life/Health Insurance Carriers
  • 7.1.6 Demography

• 7.2 Consumer Preferences and Challenges
  • 7.2.1 IT Preferences
  • 7.2.2 Technology Adoption Preferences
  • 7.2.3 IT Budget of Healthcare Facilities
  • 7.2.4 Barriers in Implementing IT

chapter Eight: Case Studies

• 8.1 George Washington University Hospital - WLAN Implementation
  • 8.1.1 Requirement for Implementation of Wireless Technologies
  • 8.1.2 Expected Benefits
  • 8.1.3 Planning and Implementation
  • 8.1.4 Cost of Implementation
  • 8.1.5 Challenges in Implementation

• 8.2 Memorial Medical Center - WLAN Implementation
  • 8.2.1 Requirement for Implementation of Wireless Technologies
  • 8.2.2 Planning and Implementation
  • 8.2.3 Challenges in Implementation

• 8.3 Good Shepherd Hospital - RFID Implementation
  • 8.3.1 Requirement for RFID Technology Adoption
  • 8.3.2 Benefits

• 8.4 Smith & Nephew - Sales Force Automation
  • 8.4.1 Planning and Implementation
  • 8.4.2 Benefits

• 8.5 Achieve Healthcare Technologies - e-Prescription
  • 8.5.1 Requirement for e-Prescription
  • 8.5.2 Benefits
  • 8.5.3 Challenges in Implementation

• 8.6 Bayer Healthcare - e-Drug Trials
  • 8.6.1 Requirement for e-Drug Trials
  • 8.6.2 Benefits
  • 8.6.3 Planning and Implementation

• 8.7 Island Health Care - Tele-homecare
  • 8.7.1 Requirement for Tele-homecare
  • 8.7.2 Benefits

• 8.8 Wireless Technologies for Patient Recovery - Remote Patient Monitoring
  • 8.8.1 Requirement for Remote Monitoring
  • 8.8.2 Telemonitoring Solution
  • 8.8.3 Results

chapter Nine: Regulatory Environment

• 9.1 Need for Regulation
• 9.2 Defining the Network Security Policy for Health Organizations
  • 9.2.1 Planning the Policy
    • 9.2.1.1 E-mail Access
    • 9.2.1.2 Content Filtering
    • 9.2.1.3 Virtual Private Networks
  • 9.2.2 Implementing the Policy
  • 9.2.3 Using the Policy

• 9.3 Regulatory Bodies and Societies
  • 9.3.1 United States Department of Health and Human Services
    • 9.3.1.1 Health Insurance Portability and Accountability Act (HIPAA)
  • 9.3.2 Health Level Seven
  • 9.3.3 Federal Communication Commission
    • 9.3.3.1 Wireless Telecommunications Bureau
  • 9.3.4 Healthcare Information and Management Systems Society
  • 9.3.5 Health Industry Business Communications Council

• 9.4 Industry Initiatives

chapter Ten: Conclusions

• 10.1 First Conclusion
• 10.2 Second Conclusion
• 10.3 Third Conclusion
• 10.4 Fourth Conclusion
• 10.5 Fifth Conclusion
• 10.6 Sixth Conclusion
• 10.7 Seventh Conclusion

chapter Eleven: Company Profiles

• 11.1 Network Infrastructure Providers
  • 11.1.1 Cisco Systems, Inc.
    • 11.1.1.1 Company Overview
    • 11.1.1.2 Geographical Presence
    • 11.1.1.3 Performance Review
    • 11.1.1.4 Product Portfolio
    • 11.1.1.5 Company Strategy
  • 11.1.2 Extreme Networks, Inc.
    • 11.1.2.1 Company Overview
    • 11.1.2.2 Geographical Presence
    • 11.1.2.3 Performance Review
    • 11.1.2.4 Product Portfolio
    • 11.1.2.5 Company Strategy
  • 11.1.3 Nortel Networks Corporation
    • 11.1.3.1 Company Overview
    • 11.1.3.2 Geographical Presence
    • 11.1.3.3 Performance Review
    • 11.1.3.4 Product Portfolio
    • 11.1.3.5 Company Strategy
  • 11.1.4 Symbol Technologies, Inc.
    • 11.1.4.1 Company Overview
    • 11.1.4.2 Geographical Presence
    • 11.1.4.3 Performance Review
    • 11.1.4.4 Product Portfolio
    • 11.1.4.5 Company Strategy
  • 11.1.5 Terabeam, Inc.
    • 11.1.5.1 Company Overview
    • 11.1.5.2 Geographical Presence
    • 11.1.5.3 Performance Review
    • 11.1.5.4 Product Portfolio
    • 11.1.5.5 Company Strategy

• 11.2 Software Providers
  • 11.2.1 Cerner Corporation
    • 11.2.1.1 Company Overview
    • 11.2.1.2 Geographical Presence
    • 11.2.1.3 Performance Review
    • 11.2.1.4 Product Portfolio
    • 11.2.1.5 Company Strategy
  • 11.2.2 Eclipsys Corporation
    • 11.2.2.1 Company Overview
    • 11.2.2.2 Geographical Presence
    • 11.2.2.3 Performance Review
    • 11.2.2.4 Product Portfolio
    • 11.2.2.5 Company Strategy
  • 11.2.3 McKesson Corporation
    • 11.2.3.1 Company Overview
    • 11.2.3.2 Geographical Presence
    • 11.2.3.3 Performance Review
    • 11.2.3.4 Product Portfolio
    • 11.2.3.5 Company Strategy
  • 11.2.4 QuadraMed Corporation
    • 11.2.4.1 Company Overview
    • 11.2.4.2 Geographical Presence
    • 11.2.4.3 Performance Review
    • 11.2.4.4 Product Portfolio
    • 11.2.4.5 Company Strategy
  • 11.2.5 Sybase, Inc.
    • 11.2.5.1 Company Overview
    • 11.2.5.2 Geographical Presence
    • 11.2.5.3 Performance Review
    • 11.2.5.4 Product Portfolio
    • 11.2.5.5 Company Strategy

• 11.3 Medical Device Manufacturers
  • 11.3.1 Cardinal Health, Inc.
    • 11.3.1.1 Company Overview
    • 11.3.1.2 Geographical Presence
    • 11.3.1.3 Performance Review
    • 11.3.1.4 Product Portfolio
    • 11.3.1.5 Company Strategy
  • 11.3.2 Datascope Corporation
    • 11.3.2.1 Company Overview
    • 11.3.2.2 Geographical Presence
    • 11.3.2.3 Performance Review
    • 11.3.2.4 Product Portfolio
    • 11.3.2.5 Company Strategy
  • 11.3.3 GE Healthcare
    • 11.3.3.1 Company Overview
    • 11.3.3.2 Geographical Presence
    • 11.3.3.3 Performance Review
    • 11.3.3.4 Product Portfolio
    • 11.3.3.5 Company Strategy
  • 11.3.4 Philips Medical Systems
    • 11.3.4.1 Company Overview
    • 11.3.4.2 Geographical Presence
    • 11.3.4.3 Performance Review
    • 11.3.4.4 Product Portfolio
    • 11.3.4.5 Company Strategy
  • 11.3.5 Siemens Medical Solutions
    • 11.3.5.1 Company Overview
    • 11.3.5.2 Geographical Presence
    • 11.3.5.3 Performance Review
    • 11.3.5.4 Product Portfolio
    • 11.3.5.5 Company Strategy

TECHNOLOGY AREA: OEM Contract Manufacturing in Medical Devices: Electronic Components and Systems

chapter 1: Executive Summary

• Scope and Methodology
  • Scope

• The Market Place
  • Purpose

• Issues and Trends in OEM Electronics and Advanced Systems
• Methodology

chapter 2: Electronics and Advanced Systems

• Sectors
• Networking and Communication Equipment
• Networking Equipment
• Communication Devices
• Optical Components and Optics
• Optical Components
• Optics
• Semiconductors
• Data Acquisition and Signal Conditioning:
• Manufacturing Software
• Manufacturing support software
• Sensors, Transducers and Detectors
• Medical Software
• Industrial Computers and Embedded Systems
• Industrial Computers
• Embedded Systems
• Test and Measurement Equipment
• Measurement Equipment
• Imaging and Video Equipment
• Video Equipment

chapter 3: Medical Device Segments

• Cardiovascular Disease
• General Surgery
• Imaging
• I.V. Diagnostics
• Ophthalmology
• 0rthopedics
• Respiratory
• Neurology
• Urology

chapter 4: Overall Global Medical Device

• Market Revenues

chapter 5: Issues and Trends in the Global

• O.E.M Market and CMO market
  • Outsourcing Challenges
  • The Business Climate
  • Reimbursement Concerns
  • Other Challenges

• Process Equipment
• Outsourcing Benefits
  • Future Potential
  • Expanding Responsibilities
  • Future Development
  • Poised For Growth

• Offshoring and Partering
  • Changing Relationships

• MPO Climate
  • A Closer Look at Outsourcing Trends
  • Getting Terms in Writing
  • Impact of Group Purchasing Power (GPO' s) and e-Commerce
  • e-Commerce
  • Technical and Organizational Aspects
  • Customer-Oriented
  • Problems
  • Product Suitability

• Global Healthcare Exchange (GHX)
  • Supply Chain Solutions
  • Market Intelligence
  • Pharma Solutions
  • Solutions that Benefit the Entire Healthcare Supply Chain
  • Exclusive Regional Dealers

• Drivers / Trends in Medical Device Distribution
  • Acquisitions
  • Growing Attractiveness of Alternative Care Distribution
  • Distribution Approaches and Commercialization Strategy

chapter 6: Electronic and Advanced Systems

• OEM Market Data and Analysis
• O.E.M ' s and Risk Adverse Medical Device Segments
  • United States OEM Contract Manufacturing Revenues
  • Drivers:-
  • Orthopedic implants
  • Orthopedics Market Overview

• Group Segments
  • United States OEM Electronic and Advanced Systems Revenues
  • Europe OEM Electronic and Advanced Systems Revenues
  • Orthopedic implants
  • European Market and Continuous Technological Innovation
  • Group Segments
  • Asia OEM Electronics and Advanced Systems Revenues
  • I.B.M - Case Study For Establishing Manufacturing in China

• Group Segments
  • Rest of World OEM Electronics and Advanced Systems Revenues

• Group Segments
  • Global OEM Electronics and Advanced Systems Revenues
  • Product Lifecycle Management (PLM) software
  • Home-Use Blood Pressure Monitors
  • European Market Overview

• Respiratory Equipment Market
  • Chronic Obstructive Pulmonary Disease (C.O.PD) Market Overview
  • Home-Use Blood Pressure Monitors
  • European Market Overview

• Respiratory Equipment Market
  • Chronic Obstructive Pulmonary Disease (C.O.PD) Market Overview

• Group Segments

chapter 7: O.E.M. Company Profiles

• Agile, Inc. (Oracle)
• Cedara Software Inc.
• Taiwan Semiconductor Manufacturing Company
• Jenoptik AG
• Products and Services
• Technologies
• Sanmina - SCI Incorporated
• Sun Microsystems
• Gems Sensors And Controls, Inc.

Appendix - Other Key OEM Companies

table of exhibits

chapter 1: Executive Summary

• Exhibit 1-1: Electronics and Advanced Systems Revenues,(in billions) 2006-2011
• Exhibit 1-2: Global OEM Revenues by Electronics and Advanced Systems Sector, 2006
• Exhibit 1-3: Key Medical Device Market Segments
• Exhibit 1-4: Examples of Combination Products

chapter 4: Overall Global Medical Device Market

• Revenues
• Exhibit: 4-1: Worldwide Non-Commodity Medical Device Sectors.
• Exhibit 4-2: Leading Medical Device Companies Revenues 2005

chapter 6: Electronic and Advanced Systems OEM

• Market Data and Analysis
• Exhibit: 6-1: United States Non-Commodity OEM Revenues 2006 - 2011 (Cardiovascular, General Surgery, Imaging, IV Diagnostics, Ophthalmology, Orthopedics, Respiratory, Neurology, Urology)
• Exhibit 6-2: United States Commodity OEM Revenues 2006 - 2011 (Cardiovascular, General Surgery, Imaging, IV Diagnostics, Ophthalmology, Orthopedics, Respiratory, Neurology, Urology)
• Exhibit 6-3: United States Estimated Revenues Cardiovascular by Sector 2006 - 2011(Networking and Communication, Industrial Computers, Medical Software, Imaging and Video, Semiconductors, Data Acquisition and Signal Conditioning, Electrical and Electronic Components, Sensors, Transducers and Detectors, Test and Measurement Equipment)
• Exhibit 6-4: United States Estimated Revenues General Surgery by Sector 2006 - 2011
• Exhibit 6-5: United States Estimated Revenues Imaging by Sector 2006 - 2011
• Exhibit 6-6: United States Estimated Revenues I.V Diagnostics by Sector 2006 - 2011
• Exhibit 6-7: United States Estimated Revenues Ophthalmology by Sector 2006 - 2011
• Exhibit 6-8: United States Estimated Revenues Orthopedics by Sector 2006 - 2011
• Exhibit 6-9: United States Estimated Revenues Respiratory by Sector 2006 - 2011
• Exhibit 6-10: United States Estimated Revenues Neurology by Sector 2006 - 2011
• Exhibit 6-11: United States Estimated Revenues Urology by Sector 2006 - 2011
• Exhibit 6-12: Europe Non Commodity OEM Revenues 2006 - 2011 (Cardiovascular, General Surgery, Imaging, IV Diagnostics, Ophthalmology, Orthopedics, Respiratory, Neurology, Urology)
• Exhibit:9-13: Europe Commodity OEM Revenues 2006 - 2011 (Cardiovascular, General Surgery, Imaging, IV Diagnostics, Ophthalmology, Orthopedics, Respiratory, Neurology, Urology)
• Exhibit 6-14: Europe Estimated Revenues Cardiovascular by Sector (Networking and Communication, Industrial Computers, Medical Software, Imaging and Video, Semiconductors, Data Acquisition and Signal Conditioning, Electrical and Electronic Components, Sensors, Transducers and Detectors, Test and Measurement Equipment)2006-2011
• Exhibit 6-15: Europe Estimated Revenues General Surgery by Sector 2006 - 2011
• Exhibit 6-16: Europe Estimated Revenues Imaging by Sector 2006 - 2011
• Exhibit 6-17: Europe Estimated Revenues I.V Diagnostics by Sector 2006 -2011
• Exhibit 6-18: Europe Estimated Revenues Ophthalmology by Sector 2006 - 2011
• Exhibit 6-19: Europe Estimated Revenues Orthopedics by Sector 2006 - 2011
• Exhibit 6-20: Europe Estimated Revenues Respiratory by Sector 2006 - 2011
• Exhibit 6-21: Europe Estimated Revenues Neurology by Sector 2006 - 2011
• Exhibit 6-22: Europe Estimated Revenues Urology by Sector 2006 - 2011
• Exhibit: 6-23: Asia Non-Commodity OEM Revenues 2006 - 2011
• Exhibit: 6-24: Asia Commodity OEM Revenues 2006 - 2011 (Cardiovascular, General Surgery, Imaging, IV Diagnostics, Ophthalmology, Orthopedics, Respiratory, Neurology, Urology)
• Exhibit 6-24: Asia Estimated Revenues Cardiovascular by Sector (Networking and Communication, Industrial Computers, Medical Software, Imaging and Video, Semiconductors, Data Acquisition and Signal Conditioning, Electrical and Electronic Components, Sensors, Transducers and Detectors, Test and Measurement Equipment) 2006 - 2011
• Exhibit 6-25: Asia Estimated Revenues General Surgery by Sector 2006 - 2011
• Exhibit 6-26: Asia Estimated Revenues Imaging by Sector 2006 - 2011
• Exhibit 6-27: Asia Estimated Revenues I.V Diagnostics by Sector 2006 - 2011
• Exhibit 6-28: Asia Estimated Revenues Ophthalmology by Sector 2006 - 2011
• Exhibit 6-29: Asia Estimated Revenues Orthopedics by Sector 2006 - 2011
• Exhibit 6-30: Asia Estimated Revenues Respiratory by Sector 2006 - 2011
• Exhibit 6-31: Asia Estimated Revenues Neurology by Sector 2006 - 2011
• Exhibit 6-32: Asia Estimated Revenues Urology by Sector 2006 - 2011
• Exhibit: 6- 31: Rest of The World Non-Commodity OEM Revenues 2006 - 2011 (Cardiovascular, General Surgery, Imaging, IV Diagnostics, Ophthalmology, Orthopedics, Respiratory, Neurology, Urology)
• Exhibit: 6-32: Rest of The World Commodity OEM Revenues 2006 - 2011 (Cardiovascular, General Surgery, Imaging, IV Diagnostics, Ophthalmology, Orthopedics, Respiratory, Neurology, Urology)
• Exhibit 6-33: Rest of The World Estimated Revenues Cardiovascular by Sector (Networking and Communication, Industrial Computers, Medical Software, Imaging and Video, Semiconductors, Data Acquisition and Signal Conditioning, Electrical and Electronic Components, Sensors, Transducers and Detectors, Test and Measurement Equipment) 2006 - 2011
• Exhibit 6-34: Rest of The World Estimated Revenues General Surgery by Sector 2006 - 2011
• Exhibit 6-35: Rest of The World Estimated Revenues Imaging by Sector 2006 - 2011
• Exhibit 6-36: Rest of The World Estimated Revenues I.V Diagnostics by Sector 2006 - 2011
• Exhibit 6-37: Rest of The World Estimated Revenues Ophthalmology by Sector 2006 - 2011
• Exhibit 6-38: Rest of The World Estimated Revenues Orthopedics by Sector 2006 - 2011
• Exhibit 6-39: Rest of The World Estimated Revenues Respiratory by Sector 2006 - 2011
• Exhibit 6-40: Rest of The World Estimated Revenues Neurology by Sector 2006 - 2011
• Exhibit 6-41: Rest of The World Estimated Revenues Urology by Sector 2006 - 2011
• Exhibit: 6-42: Global Non-Commodity OEM Revenues 2006 - 2011 (Cardiovascular, General Surgery, Imaging, IV Diagnostics, Ophthalmology, Orthopedics, Respiratory, Neurology, Urology)
• Exhibit: 6-43: Global Commodity OEM Revenues 2006 - 2011 (Cardiovascular, General Surgery, Imaging, IV Diagnostics, Ophthalmology, Orthopedics, Respiratory, Neurology, Urology)
• Exhibit 6-44: Global Estimated Revenues Cardiovascular (Networking and Communication, Industrial Computers, Medical Software, Imaging and Video, Semiconductors, Data Acquisition and Signal Conditioning, Electrical and Electronic Components, Sensors, Transducers and Detectors, Test and Measurement Equipment) by Sector 2006 - 2011
• Exhibit 6-45: Global Estimated Revenues General Surgery by Sector 2006 - 2011
• Exhibit 6-46: Global Estimated Revenues Imaging by Sector 2006 - 2011
• Exhibit 6-47: Global Estimated Revenues I.V. Diagnostics by Sector 2006 - 2011
• Exhibit 6-48: Global Estimated Revenues Ophthalmology by Sector 2006 - 2011
• Exhibit 6-49: Global Estimated Revenues Orthopedics by Sector 2006 - 2011
• Exhibit 6-50: Global Estimated Revenues Respiratory by Sector 2006 - 2011
• Exhibit 6-51: Global Estimated Revenues Neurology 2006 - 2011
• Exhibit 6-52: Global Estimated Revenues Urology 2006 - 2011
• Exhibit 6-53: Breakdown of Global OEM Revenues by Electronics and Advanced Systems Sector, 2006 (Networking and Communication, Industrial Computers, Medical Software, Imaging and Video, Semiconductors, Data Acquisition and Signal Conditioning, Electrical and Electronic Components, Sensors, Transducers and Detectors, Test and Measurement Equipment)

TECHNOLOGY AREA: RFID Opportunies in Healthcare in the U.S.

chapter ONE: Executive SummarY

• 1.1 Healthcare Industry
• 1.2 Identification Technologies
  • 1.2.1 Radio Frequency Identification (RFID)

• 1.3 Definition And Scope
• 1.4 RFID in Healthcare
  • 1.4.1 Key RFID Applications in Healthcare
  • 1.4.3 Cost of RFID Deployment
    • 1.4.3.1 Implementing RFID
• 1.5 Market Overview

• 1.5.1 Market Size
• 1.5.2 Market Segmentation
  • 1.5.2.1 Based on Implementation Cost
  • 1.5.2.2 Based on Transponder and Decoder Frequencies
• 1.5.3 Drivers and Inhibitor
  • 1.5.3.1 Growth Drivers
  • 1.5.3.2 Growth Inhibitors
• 1.5.4 Emerging Applications and Future Outlook

• 1.6 Industry Value Chain
  • 1.6.1 Hardware Vendors
  • 1.6.2 Software and Application Vendors
  • 1.6.3 Healthcare-specific RFID Vendors

• 1.7 Demand Side Analysis
  • 1.7.1 Customer Segments
  • 1.7.3 Customer Issues and Needs
• 1.9 Conclusions

chapter TWO: Introduction to RFID in Healthcare

• 2.1 Healthcare Industry
  • 2.1.1 Introduction
  • 2.1.2 Trends
  • 2.1.3 Challenges

• 2.2 Identification Technologies
  • 2.2.1 Introduction
  • 2.2.2 Different Identification Technologies
    • 2.2.2.1 Bar codes
    • 2.2.2.2 Optical Character Reader (OCR)
    • 2.2.2.3 Biometrics
    • 2.2.2.4 Computer Vision
    • 2.2.2.5 Magnetic Ink
    • 2.2.2.6 Smart Cards
    • 2.2.2.7 Contact Memory
    • 2.2.2.8 Magnetic Stripe
    • 2.2.2.9 Bluetooth
    • 2.2.2.10 Global Positioning System
    • 2.2.2.11 RFID
    • RFID Application Areas
    • Market Overview of RFID Technologies
  • 2.2.3 Select Identification Technologies Compared on Different Parameters
  • 2.2.4 Application of Identification Technologies

• 2.3 RFID in Healthcare
  • Need for RFID
  • Benefits of RFID in Healthcare
  • 2.3.1 US - The Best Market for RFID Opportunities in Healthcare
  • 2.3.2 Trends
  • 2.3.3 Challenges

chapter THREE: BENEFITS OF RFID APPLICATIONS

• 3.1 Introduction
• 3.2 Healthcare Industry Segmentation for RFID Applications
• 3.3 Key Applications of RFID
  • 3.3.1 Mobile Asset Tracking
  • Benefits of Mobile Asset Tracking
  • 3.3.2 Patient Tracking
  • 3.3.3 Patient Identification
  • Need for Accurate Patient Identification
  • RFID-enabled Patient Identification Systems
  • Benefits of RFID-enabled Patient Identification Systems
  • 3.3.4 Medication Tracking and Dispensing
  • Benefits of Automated Dispensing Systems

• 3.4 Key Benefits of RFID in Healthcare
  • 3.4.1 Applications of RFID in Pharmaceutical Industry
    • 3.4.1.1 Need for RFID in Pharmaceutical Industry
  • 3.4.2 Applications of RFID in Hospitals
    • 3.4.2.1 Need for RFID in Hospitals
    • 3.4.2.2 RFID Benefits for Hospitals

chapter FOUR: RFID Technology

• 4.1 Basics of RFID technology
  • 4.1.1 Configurations of RFID Systems
  • 4.1.2 Parameters for Distinguishing RFID Systems
  • 4.1.3 Classification of RFID Systems
    • 4.1.3.1 Classification of RFID Systems on the Basis of Performance
    • 4.1.3.2 Classification of RFID Systems on the Basis of their Range
    • 4.1.3.3 Classification of RFID Systems on the Basis of Auto ID Centre
  • 4.1.4 Security Aspects and Possible Attacks on RFID Systems

• 4.2 RFID Infrastructure

chapter FIVE: Implementing RFID in HealthcarE

• 5.1 RFID Infrastructure Deploymen
  • 5.1.1 Implementing RFID in the Pharmaceutical Supply Chai
  • 5.1.2 Implementing RFID in Hospital
  • 5.1.3 Scaling from Pilot to Implementation Stage
• 5.2 Cost of RFID Infrastructure Deployment
• 5.3 Return on Investment (ROI)
  • 5.3.1 Estimated ROI and Benefits for a Hospital

chapter SIX: Market Overview of RFID in HealthcarE

• 6.1 Market Definition
• 6.2 Market Size and Growth Rate
  • 6.2.1 Market Segmentation - Based on Implementation Cost Components
  • 6.2.2 Market Segmentation - Based on Transponder and Decoder IC Frequency

• 6.3 Competitive Landscape
  • 6.3.1 Segmentation of Types of Players
  • 6.3.2 Industry Value Chain and Key Players

• 6.4 Drivers and Inhibitor
  • 6.4.1 Growth Drivers
    • 6.4.1.1 Industry Initiatives
  • 6.4.2 Growth Inhibitors

• 6.5 Emerging Trends and Outlook
  • 6.5.1 Trend
  • 6.5.2 Emerging Applications and Outloo

chapter SEVEN: Demand Side AnalysiS

• 7.1 Consumer Statistics
  • 7.1.1 Hospital
    • 7.1.1.1 RFID Adoption in Hospitals
  • 7.1.2 Pharmaceutical Manufacturers
    • 7.1.2.1 RFID Technology in Pharmaceutical Companies
  • 7.1.3 Nursing Homes
    • 7.1.3.1 RFID Technology in Nursing Homes
  • 7.1.4 Pharmacies
    • 7.1.4.1 RFID in Pharmacies
  • 7.1.5 Medical and Diagnostic Laboratories
    • 7.1.5.1 RFID in Medical and Diagnostic Laboratories

• 7.2 Consumer Issues and Preferences

chapter EIGHT: Case Studies

• 8.3 Charge Capture Management
• 8.4 Inventory Reduction
• 8.5 Expiration Management
  • Benefits of Implementation

• 8.1 RFID for Inventory Labeling - Pharmaceutical Supply Chain
  • Background
  • Solution - Executing the Pilot
  • System and Technology
  • Future

• 8.2 RFID for Blood Transfusion Error Reduction
  • Background - Need for RFID in Blood Transfusion
  • Solution

chapter NINE: Regulatory Environment

• 9.2 Regulatory Bodies and Societies
  • 9.2.1 International Bodies
    • 9.2.1.1 International Standards Organization (ISO)
    • 9.2.1.2 International Electrotechnical Commission (IEC)
    • 9.2.1.3 International Telecommunications Union (ITU)
  • 9.2.2 National Bodies
    • 9.2.2.1 American National Standards Institute (ANSI)
  • 9.2.3 Industrial Bodies
    • 9.2.3.1 Electronic Product Code (EPC)
  • 9.2.4 Other Bodies
    • 9.2.4.1 Department of Health and Human Services (HHS) in the United States
    • Limitations
    • HIPAA Penalties
    • 9.2.4.2 Healthcare Distribution and Management Association (HDMA)
• 9.2 Standards

chapter TEN: Conclusions

• 10.1 First Conclusion
• 10.2 Second Conclusion
• 10.3 Third Conclusion
• 10.4 Fourth Conclusion
• 10.5 Fifth Conclusion
• 10.6 Sixth Conclusion
• 10.7 Seventh Conclusion
• 10.8 Eighth Conclusion

chapter ELEVEN: Company Profiles

• 11.1 Alien Technology
  • 11.1.1 Key Facts
  • 11.1.2 Company Overview
  • 11.1.3 Geographical Presence
  • 11.1.4 Key Competitors
  • 11.1.5 Performance Review
  • 11.1.6 Product Portfolio
  • 11.1.7 Use of RFID in Healthcare Solutions
  • 11.1.8 Company Strategy
• 11.2 Atmel Corporation
  • 11.2.1 Key Facts
  • 11.2.2 Company Overview
  • 11.2.3 Geographical Presence
  • 11.2.4 Key Competitors
  • 11.2.5 Performance Review
    • 11.2.5.1 Revenue Performance
    • 11.2.5.2 Performance of Geographic Segments
    • 11.2.5.3 Performance of Business Segments
    • 11.2.5.4 Performance of the RF and Automotive Business Segment
  • 11.2.6 Product Portfolio
  • 11.2.7 Company Strategy

• 11.3 Cisco Systems, Inc.
  • 11.3.1 Key Facts
  • 11.3.2 Company Overview
  • 11.3.4 Key Competitors
  • 11.3.5 Performance Review
  • 11.3.6 Product Portfolio
  • 11.3.7 Company Strategy

• 11.4 Exavera Technologies
  • 11.4.1 Key Facts
  • 11.4.2 Company Overview
  • 11.4.3 Product Portfolio
  • 11.4.4 Company Strategy

• 11.5 Intermec, Inc.
  • 11.5.1 Key Facts
  • 11.5.2 Company Overview
  • 11.5.3 Geographical Presence
  • 11.5.4 Key Competitors
  • 11.5.5 Performance Review
  • 11.5.6 Product Portfolio
  • 11.5.7 RFID-specific Product Portfolio in Healthcare
    • 11.5.6.1 Supplies
    • 11.5.6.2 Asset Tracking
    • 11.5.6.3 Patient Tracking and Administration
    • 11.5.6.4 Security and records
    • 11.5.6.5 Laboratory
    • 11.5.6.6 Pharmacy
    • 11.5.6.7 Technologies added to Products
  • 11.5.8 Company Strategy

• 11.6 Manhattan Associates
  • 11.6.1 Key Facts
  • 11.6.2 Company Overview
  • 11.6.3 Geographical Presence
  • 11.6.4 Key Competitors
  • 11.6.5 Performance Review
  • 11.6.6 Product Portfolio
  • 11.5.7 RFID-specific Product Portfolio
  • 11.6.8 Company Strategy

• 11.7 Mobile Aspects
  • 11.7.1 Key Facts
  • 11.7.2 Company Overview
  • 11.7.3 Product Portfolio
  • 11.7.4 Company Strategy

• 11.8 PanGo Networks
  • 11.8.1 Key Facts
  • 11.8.2 Company Overview
  • 11.8.3 Product Portfolio
  • 11.8.4 Company Strategy
    • 11.8.3.1 Technology Partnerships
    • 11.8.3.2 Sales and Distribution

• 11.9 Symbol Technologies, Inc.
• 11.9.1 Key Facts
• 11.9.2 Company Overview
• 11.9.4 Key Competitors
• 11.9.5 Performance Review
• 11.9.6 Product Portfolio
• 11.9.8 Company Strategy

• 11.10 Tagsys
  • 11.10.1 Key Facts
  • 11.10.1 Company Overview
  • 11.10.2 Performance Review
  • 11.10.3 Product Portfolio
  • 11.10.4 Company Strategy

• 11.11 Texas Instruments
  • 11.11.1 Key Facts
  • 11.11.2 Company Overview
  • 11.11.3 Geographical Presence
  • 11.11.4 Key Competitors
  • 11.11.5 Performance Review
  • 11.11.6 Product Port
  • 11.11.7 RFID-specific Product Portfolio
  • 11.11.8 Company Strategy

List of Exhibits

chapter ONE: Executive Summary

• Figure 1-1: Market Forecast for RFID in Healthcare (2005-2010) (in USD million
• Figure 1-2: Cost of Implementation of RFID (2004 and 2008)
• Figure 1-3: Key Market Drivers - RFID Opportunities in Healthcare
• Table 1-1: Major RFID Benefits for Users
• Figure 1-4: Top Business Issues Being Faced by Healthcare Provider Managers (2005-2006)
• Figure 1-5: Barriers to Implementation of RFID in Healthcare (2005-2006)

chapter TWO: Introduction to RFID in Healthcare

• Figure 2-2: Application of Vision Technologies in Different Fields
• Table 2-1: Different Classes of Bluetooth Technology and Performance Parameters
• Table 2-2: Bluetooth Technology Versions and Properties
• Table 2-3: Application of GPS in Different Fields
• Figure 2-3: Value Chain of the RFID Industry
• Table 2-4: Key Differences between Bar Codes and RFID
• Table 2-5: Vertical-wise Application and Benefits of RFID
• Figure 2-4: Worldwide Market for RFID (2006-2013)
• Figure 2-5: Drivers
• Table 2-6: Select Identification Technologies Compared on Different Parameters
• Figure 2-6 : Classification of Identification Technologies Applications
• Figure 2-7: US Healthcare Spending (2000-2015)
• Table 2-7: Challenges Associated with the Adoption of RFID in Healthcare

chapter THREE: BENEFITS OF RFID in Healthcare

• Figure 3-1: Healthcare Industry Segmentation and Scope of RFID Applications
• Table 3-1: Challenges Associated with Adoption of RFID in Healthcare
• Figure 3-2: Step-by-step Working of RFID-enabled Dispensing Systems

chapter FOUR: RFID Technology

• Figure 4-1: Parameters for Distinguishing RFID Systems
• Table 4-1: Classification of Radio Frequency in Terms of Performance
• Parameters
• Table 4-2: Applications of RFID with Different Ranges
• Table 4-3: Comparison of Active and Passive RFID in Terms of Different Performance Parameters
• Figure 4-2: Parameters for Classification of RFID Systems
• Table 4-4: Auto ID Centre Classification of RFID Systems
• Table 4-5: Types of Attacks on RFID Systems and their Countermeasures
• Figure 4-3: Classification of RFID Tags

chapter FIVE: Implementing A RFID SYSTEM

• Table 5-1: Planning and Implementing RFID Systems
• Figure 5-1: RFID Implementation - Time Taken for Various Stages
• Table 5-2: Phase-wise Proposed Deployment of RFID in the Pharmaceutical Supply Chain
• Figure 5-2: Components of an RFID System
• Figure 5-3: Cost of Implementation of RFID (2004 and 2008) (percent)
• Table 5-3: Estimated Benefits for a Hospital (in USD)
• Table 5-4 : Estimated Costs Incurred by a Hospital over a Period of Five Years (in USD)
• Table 5-5: Estimated Net Benefits for a Hospital (in USD)
• Table 5-6: Estimated Return on Investment Following the Implementation of
• RFID - Large Pharmaceutical Manufacturers and Distributors (2004)

chapter six: Market Overview of RFID in Healthcare

• Figure 6-1: Market Forecast for RFID in Healthcare 2005-2010
• Figure 6-2: RFID Market Segmentation - Based on Implementation Cost
• Components (2005 and 2008) (in USD million)
• Figure 6-3: RFID Market Segmentation - Based on Transponder and Decoder IC Frequency (2005 and 2008) ($millions)
• Figure 6-4: Competitive Landscape - Types of Players (RFID in Healthcare)

chapter seven: Demand-Side Analysis

• Table 7-1: Main Types of RFID Technology Users in the Healthcare Industry
• Figure 7-1: Number of Hospitals in the US (1975-2005)
• Figure 7-2: Number of Hospital Mergers in the US (1999-20
• Figure 7-3: Adoption of RFID by US Hospitals (2005-2011)
• Table 7-2: US Hospitals that have Adopted RFID - Sample List
• Table 7-3: RFID Technologies-enabled Pharmaceutical and Pharmacy Companies in the US
• Figure 7-4: Number of Nursing Homes (2000-2004)
• Figure 7-5: Number of Pharmacies and Drug Stores (2000-2004)
• Figure 7-6: Number of Medical and Diagnostic Laboratories (2000-2004)
• Table 7-4: Major RFID Benefits Cited by Users
• Figure 7-7: Implementation Priorities of Healthcare Organizations in the US (2005-2008)
• Figure 7-8: Top Business Issues Being Faced by Healthcare Provider Managers (2005-2006)
• Figure 7-9: Barriers to Implementation of RFID in Healthcare 2005-2006

chapter EIGHT: Case Studies

• Table 8-1: Post-pilot Charge Capture Analysis
• Figure 8-1: Blood Handling Process in Transfusion Centers

chapter nine: Regulatory Environment

• Figure 9-1: Standards Organization Overview
• Figure 9-2: Hierarchical Structure of EPCglobal Network
• Table 9-1: Divisions of HAG and their Roles
• Table 9-2: Divisions of SAG and their Roles
• Table 9-3: ISO/IEC RFID Standards
• Table 9-4: EPCglobal RFID System Standards Release 1.0
• Table 9-5: ETSI Generic RFID Standards

chapter TEN: Conclusions

• Table 10-1: Identification Technologies and Their Application Areas
• Table 10-2: Key Differences between Bar Codes and RFID
• Figure 10-1 : Trend Comparison between the Worldwide RFID Market and the US RFID Healthcare Market (2006-2012)
• Figure 10-2: Adoption of RFID by US Hospitals (2005-2011)
• Table 10-3: Current and Future Applications of RFID in Healthcare
• Figure 10-3: RFID Market Segmentation - Based on Implementation Cost Components (2005 and 2008) (in USD million)

chapter ELEVEN :Company Profiles

• Table 11-1: Corporate Details - Alien Technology
• Table 11-2: Key Executives - Alien Technology
• Table 11-3: Geographical Presence
• Figure 11-1: Revenue - 2003-2005 (in USD million)
• Table 11-4: Corporate Details - Atmel Corporation
• Table 11-5: Key Executives - Atmel Corporation
• Table 11-6: Geographical Presence and Subsidiaries - Atmel Corporation
• Figure 11-2: Annual Revenues - 2001-2006 (in USD million)
• Figure 11-3: Revenues by Geographic Segments - 2006
• Figure 11-4: Revenues by Business Segments - 2006
• Figure 11-5: Annual Revenues of the RF and Automotive Business Segment - 2001-2006 (in USD million)
• Table 11-7: Corporate Details - Cisco
• Table 11-8: Key Executives - Cisco
• Table 11-9: Geographical Presence - Cisco
• Figure 11-6: Cisco Revenue - 2002-2006 (in USD million)
• Figure 11-7: Cisco Revenue Break-up by Business Segments - 2006
• Figure 11-8: Cisco Revenue Break-up by Geography - 2006
• Table 11-10: Corporate Details - Exavera Technologies
• Table 11-11: Key Executives - Exavera Technologies
• Table 11-12: Corporate Details - Intermec, Inc.
• Table 11-13: Geographical Presence and Subsidiaries - Intermec, Inc.
• Figure 11-9: Revenue - 2002-2006 (in USD million)
• Table 11-14: Corporate Details - Manhattan Associates
• Table 11-15: Key Executives - Manhattan Associates
• Table 11-16: Geographical Presence - Manhattan Associates
• Figure 11-10: Revenue - 2002-2006 (in USD million) Manhattan Associates
• Figure 11-11: Geographic Break-up of Net Sales - Manhattan Associate,s, 2006
• Figure 11-12: Segment-wise Revenue Break-up - Manhattan Associates, 2006
• Table 11-17: RFID-specific Product Portfolio - Manhattan Associates
• Table 11-18: Strategic Alliance Partners - Manhattan Associates
• Table 11-19: Corporate Details - Mobile Aspects
• Table 11-20: Key Executives - Mobile Aspects
• Table 11-21: Corporate Details - PanGo Networks
• Table 11-22: Key Executives - PanGo Networks
• Table 11-23: Corporate Details - Symbol Technologies
• Table 11-24: Key Executives - Symbol Technologies
• Table 11-25: Geographical Presence - Symbol Technologies
• Figure 11-13: Symbol Technolgies Revenue - 2001-2005
• Figure 11-14: Symbol Technologies Geographic Break-up of Net Sales - 2005 (in percent)
• Figure 11-15: Break-up of Worldwide Product Sales, 2005 (in percent)
• Table 11-26: Healthcare-specific Solutions - Symbol Technologies
• Table 11-27: RFID-specific Product Portfolio - Symbol Technologies
• Table 11-28: Corporate Details - Tagsys
• Table 11-29: Key Executives - Tagsys
• Figure 11-16: Tagsys: Amount of Finance Raised per annum
• Table 11-30: Pharmaceutical and Life Sciences Products - Tagsys
• Table 11-31: Corporate Details - Texas Instruments
• Table 11-32: Key Executives - Texas Instruments
• Figure 11-17: Employment Details - Texas Instruments
• Table 11-32: Major Worldwide Design and Manufacturing Locations - Texas Instruments
• Figure 11-18: Revenue Break-up - 2001-2006 (in USD million)
• Figure 11-19: Revenue Break-up - Business Segments (2006)
• Figure 11-20: Revenue Break-up - Semiconductor Business Segment (2005)
• Table 11-33: Product Offering - TI RFID Solutions

TECHNOLOGY AREA: Virtual Reality in Healthcare

chapter One: Executive Summary

• 1.1 The Healthcare Industry
• 1.2 Information Technology (IT) Market in Healthcare
• 1.3 Virtual Reality Industry
• 1.4 Virtual Reality Systems
• 1.5 Virtual Reality Market
  • 1.5.1 Market Definition
  • 1.5.2 Market Overview

• 1.6 Virtual Reality Market in Healthcare
• 1.7 Application of Virtual Reality In Healthcare
• 1.8 Demand-Side Analysis
• 1.9 Regulatory Environment
• 1.10 Conclusions and Future Outlook

chapter Two: Overview

• 2.1 Healthcare Industry
  • 2.1.1 Market Overview
  • 2.1.2 Categorization of Healthcare Services
    • 2.1.2.1 Healthcare Service Providers
    • 2.1.2.2 Healthcare Industry Value Chain
  • 2.1.3 Trends
  • 2.1.4 Challenges

• 2.2 Information Technology (IT) Market in Healthcare
• 2.3 Virtual Reality Industry
  • 2.3.1 Definition
  • 2.3.2 Applications
  • 2.3.3 Virtual Reality Systems
    • 2.3.3.1 Design Processes of VR System
    • 2.3.3.2 Classification of VR Systems
    • 2.3.3.3 Input Devices
    • 2.3.3.4 Feedback
  • 2.3.4 Virtual Reality Market
    • 2.3.4.1 Overview
    • 2.3.4.2 Government Initiatives
  • 2.3.5 Analysis of Factors Affecting the Virtual Reality Industry
    • 2.3.5.1 Projection Display Systems
    • 2.3.5.2 Semiconductor Devices Industry
    • 2.3.5.3 Computer Product and Computer Peripherals Industry
  • 2.3.6 Trends
    • 2.3.6.1 Widespread Use of Internet Provides Affordable Solutions
    • 2.3.6.2 Digitization of Medical Records
  • 2.3.7 Challenges
    • 2.3.7.1 Technology Limitations
    • 2.3.7.2 Prohibitive Cost of Systems
    • 2.3.7.3 Concerns about Safety and Health
  • 2.3.8 Commercialization of VR Systems

chapter Three: Opportunities for Virtual Reality in Healthcare

• 3.1 Virtual Reality in Health Industry
  • 3.1.1 Introduction
    • 3.1.1.1 Market Overview
  • 3.1.2 Advantages
    • 3.1.2.1 Hands-On Training
    • 3.1.2.2 Assessment and Certification of Skills
    • 3.1.2.3 Training in Newly Discovered Medical Protocols
    • 3.1.2.4 Risk-Free Training
    • 3.1.2.5 Gaining Confidence in New and Complex Procedures
    • 3.1.2.6 Insights into Medical Condition of the Patient
  • 3.1.3 Challenges
  • 3.1.3.1 Medical Economics
  • 3.1.3.2 Legal Implications
  • 3.1.3.3 Insufficient Interfaces

• 3.2 Healthcare Industry Segmentation for Virtual Reality Applications
  • 3.2.1 Applications of Virtual Reality in Surgery
    • 3.2.1.1 Pre-Operative Planning
    • 3.2.1.2 Robot-Assisted Surgery
    • 3.2.1.3 Minimum Invasive Surgery
    • 3.2.1.4 Augmented Reality Surgery
  • 3.2.2 Application of Virtual Reality in Rehabilitation and Therapy
    • 3.2.2.1 Psychological and Physical Rehabilitation
    • 3.2.2.2 Tele-rehabilitation
  • 3.2.3 Application of Virtual Reality in Visualization of Medical Data
    • 3.2.3.1 Insights into the Medical Condition of a Patient
    • 3.2.3.2 Diagnostics
  • 3.2.4 Application of Virtual Reality in Education and Training
    • 3.2.4.1 Interactive Learning
    • 3.2.4.2 Teaching of Anatomy
    • 3.2.4.3 Performance Analysis
    • 3.2.4.4 Training on Uncommon Emergency Procedures
    • 3.2.4.5 Training in Surgery

• 3.3. Opportunities in Virtual Reality Market based on Therapeutic Areas
  • 3.3.1 Cardiology
  • 3.3.2 Psychology
  • 3.3.3 Radiology
  • 3.3.4 Oncology

chapter Four: Demand-Side Analysis

• 4.1 Introduction
• 4.2 Key Customer Segments
  • 4.2.1 Department of Defense
    • 4.2.1.1 Overview
    • 4.2.1.2 The US DoD' s Expenditure on Healthcare
    • 4.2.1.3 Virtual Reality Requirement for US DoD
  • 4.2.2 Medical Schools
    • 4.2.2.1 Shortage of Physicians: Need to Provide Assistance to a Large Number of Professionals
    • 4.2.2.2 High Cost of Training
    • 4.2.2.3 Lifelong Training in Advanced Technology for Physicians
    • 4.2.2.4 Objective Assessment
  • 4.2.3 Hospitals
    • 4.2.3.1 Shrinking Margins
    • 4.2.3.2 Medical Negligence: Third Largest Cause of Deaths in US
  • 4.2.4 Manufacturers of Medical Equipment
    • 4.2.4.1 Overview
    • 4.2.4.2 Challenges Faced by Manufacturers while Introducing New Products
    • 4.2.4.3 VR Solutions for the Challenges Faced by Medical Equipment Manufacturers

chapter Five: Case Studies

• 5.1 CASE STUDY: Virtual Reality in Rehabilitation and Therapy
  • 5.1.1 Use of Virtual Reality to Combat Post-Traumatic Stress Disorder (PTSD)
  • 5.1.2 Use of Virtual Reality to Facilitate Pain Distraction

• 5.2 CASE STUDY: Virtual Reality in Visualization of Medical Data
  • 5.2.1 Use of Virtual Reality for Diagnosis of a Calcified Heart

• 5.3 CASE STUDY: Virtual Reality in Surgery
  • 5.3.1 Use of Virtual Reality for Removing Brain Tumors

• 5.4 CASE STUDY: Virtual Reality in Education and Training
  • 5.4.1 Use of Virtual Reality for Training Professionals in Laparoscopic Cholecystectomy.....

chapter Six: Regulatory Environment

• 6.1 Introduction
• 6.2 International Standards Organization
  • 6.2.1 ISO 13407:1999 - Human-Centered Design Processes for Interactive Systems

• 6.3 Food and Drug Administration
• 6.4 Health Insurance Portability and Accountability Act
  • 6.4.1 Privacy Rule
  • 6.4.2 Security Rule

chapter Seven: Conclusions

• 7.1 First Conclusion
• 7.2 Second Conclusion
• 7.3 Third Conclusion
• 7.4 Fourth Conclusion
• 7.5 Fifth Conclusion
• 7.6 Sixth Conclusion
• 7.7 Seventh Conclusion
• 7.8 Eighth Conclusion
• 7.9 Ninth Conclusion

chapter Eight: Company ProfileS

• 8.1 Ascension Technology Corporation
  • 8.1.1 Key Facts
  • 8.1.2 Company Overview
  • 8.1.3 Geographical Presence
  • 8.1.4 Business Line and Product Portfolio
  • 8.1.5 Key Executives
  • 8.1.6 Recent Developments
  • 8.1.7 Company Strategy

• 8.2 Fifth Dimension
  • 8.2.1 Key Facts
  • 8.2.2 Company Overview
  • 8.2.3 Geographical Presence
  • 8.2.4 Business Lines
  • 8.2.5 Key Executives
  • 8.2.6 Product Portfolio
  • 8.2.7 Company Strategy

• 8.3 Immersion Corporation
  • 8.3.1 Key Facts
  • 8.3.2 Company Overview
  • 8.3.3 Geographical Presence and Subsidiaries
  • 8.3.4 Business Lines
  • 8.3.5 Key Executives
  • 8.3.6 Product Portfolio
  • 8.3.7 Performance Review
    • 8.3.7.1 Revenue Performance
    • 8.3.7.2 Performance of Geographic Segments
    • 8.3.7.3 Revenues Earned by Immersion Medical, Inc.
  • 8.3.8 Recent Developments
  • 8.3.9 Company Strategy

• 8.4 Intuitive Surgical, Inc.
  • 8.4.1 Key Facts
  • 8.4.2 Company Overview
  • 8.4.3 Geographical Presence
  • 8.4.4 Key Executives
  • 8.4.5 Business Lines and Product Portfolio
  • 8.4.6 Performance Review
    • 8.4.6.1 Revenue Performance
    • 8.4.6.2 Performance of Product Segments
  • 8.4.7 Recent Developments
    • 8.4.7.1 Technology Acquisitions
    • 8.4.7.2 Reorganization of Its International Operation
  • 8.4.8 Company Strategy

• 8.5 Mechdyne Corporation
  • 8.5.1 Key Facts
  • 8.5.2 Company Overview
  • 8.5.3 Geographical Presence
  • 8.5.4 Business Lines and Product Portfolio
  • 8.5.5 Key Executives
  • 8.5.6 Recent Developments
  • 8.5.7 Company Strategy

• 8.6 Medtronic, Inc.
  • 8.6.1 Key Facts
  • 8.6.2 Company Overview
  • 8.6.3 Geographical Presence and Subsidiaries
  • 8.6.4 Business Lines
  • 8.6.5 Key Executives
  • 8.6.6 Product Portfolio
  • 8.6.7 Performance Review
    • 8.6.7.1 Revenue Performance
    • 8.6.7.2 Performance of Geographic Segments
    • 8.6.7.3 Performance of Operating Segments
  • 8.6.8 Recent Developments
  • 8.6.9 Company Strategy

• 8.7 Mentice AB
  • 8.7.1 Key Facts
  • 8.7.2 Company Overview
  • 8.7.3 Geographical Presence
  • 8.7.4 Business Lines and Product Portfolio
  • 8.7.5 Key Executives
  • 8.7.6 Company Strategy

TABLE OF EXHIBITS

chapter One: Executive Summary

• Figure 1-1: Flow of Processes in a VR System
• Figure 1-2: Worldwide Market Size for All VR Applications (2000-2010)
• Figure 1-3: Virtual Reality Market in US Healthcare Sector (2004-2010)

chapter Two: Overview

• Figure 2-1: Healthcare vs. Other Sectors in Contribution to US GDP (2006)
• Figure 2-2: US Healthcare Spending (2005-2015)
• Figure 2-3: Market Players in Healthcare Industry
• Figure 2-4: Value Chain of Healthcare Industry
• Figure 2-5: The US Spending on HIT (2002-2008)
• Figure 2-6: Complete VR System
• Figure 2-7: Flow of Processes in VR System
• Figure 2-8: Classification of VR Systems
• Table 2-1: Features of VR Systems
• Figure 2-9: Market Size for VR Applications (2000-2006)
• Figure 2-10: Market Size Forecast for VR Applications (2007-2010)
• Figure 2-11: Break-up of VR Market - By Geography (2006)
• Figure 2-12: Break-up of Global VR Market (2006)
• Table 2-2: Project, Institute, and Funding Provided under ATP (till 2006)
• Figure 2-13: Projector Display Industry - Value of Shipments vs PPI (2003-2006)
• Figure 2-14: Computing Speed of Intel Processors (1994-2006)
• Figure 2-15: Semiconductor Industry - Value of Shipment vs PPI (2002-2006)
• Figure 2-16: Computer Manufacturing Industry - Value of Shipment vs PPI (2002-2006)
• Figure 2-17: Commercialization Cycle for Virtual Reality Products

chapter Three: Opportunities for Virtual Reality in Healthcare

• Figure 3-1: VR Market in US Healthcare Sector (2004-2010)
• Figure 3-2: Break-up of VR Application Areas in US Healthcare Market (2006)
• Table 3-1: Key Conferences Covering VR Industry
• Figure 3-3: Applications of Virtual Reality in Health Industry
• Figure 3-4: Market Size for VR in Surgery (2004-2010)
• Figure 3-5: Application of VR in Surgery
• Figure 3-6: Market for VR in Rehabilitation and Therapy (2004-2010)
• Figure 3-7: Market for VR in Visualization of Medical Data (2004-2010)
• Figure 3-8: Application of Virtual Reality in Education and Training
• Figure 3-9: Market Size for VR in Education and Training (2004-2010)
• Table 3-2: Annual Data: Cost of Illness and Number of Patients
• Figure 3-10: Direct Costs of Cardiovascular Diseases: 2007 (in USD billion)

chapter Four: Demand-Side Analysis

• Figure 4-1: Break-up of US DoD' s Healthcare Expenditure (2006)
• Figure 4-2: US Department of Defense Expenditure on Health (2003-2007)
• Figure 4-3: Comparative Index: Number of Physicians Present and Required per 100,000 US population
• Table 4-1: Number of Doctors in US: Age Distribution
• Figure 4-5: Number of Hospitals in US (1975-2005)
• Table 4-2: Causes of Deaths in Hospitals
• Figure 4-6: Market Supply for Electromedical Equipment in US (2001-2006)

chapter Five: Case Studies

• Figure 5-1: Patient Pain Ratings with the Use of Morphine During Wound Care
• Figure 5-2: Patient Pain Ratings with/without the Use of VR during Wound Care

chapter Eight: Company Profiles

• Table 8-1: Corporate Details of Ascension Technology Corporation
• Table 8-2: Resellers for Ascension Technology
• Table 8-3: Third-Party Devices and Vendors
• Table 8-4: Applications and Procedures
• Table 8-5: Key Executives: Mentice
• Table 8-6: Corporate Details of Fifth Dimension
• Table 8-7: Resellers for Fifth Dimension
• Table 8-8: Key Executives: Fifth Dimension
• Table 8-9: Self-developed Products
• Table 8-10: Hardware Products Distributed - Company and Product
• Table 8-11: Corporate Details of Immersion Corporation
• Table 8-12: Geographical Presence of Immersion Corporation
• Table 8-13: Key Executives of Immersion Corporation
• Table 8-14: Product Portfolio
• Figure 8-1: Annual Revenues of Immersion Corporation (2001-2006)
• Figure 8-2: Revenues Earned by Immersion Corporation in 2006
• Figure 8-3: Annual Revenues of Immersion Medical, Inc. (2002-2006)
• Table 8-15: Corporate Details of Intuitive Surgical, Inc.
• Table 8-16: Key Executives of Intuitive Surgical, Inc.
• Figure 8-4: Intuitive Surgical Revenue Performance (2001-2005)
• Figure 8-5: Intuitive Surgical Revenues by Product Segment (2006)
• Table 8-17: Corporate Details of Mechdyne Corporation
• Table 8-18: Key Executives of Mechdyne
• Table 8-19: Corporate Details of Medtronic, Inc.
• Table 8-20: Geographical Presence of Medtronic, Inc.
• Table 8-21: Key Executives of Medtronic, Inc.
• Table 8-22: Product Portfolio
• Figure 8-6: Revenues of Medtronic, Inc. (2002-2006)
• Figure 8-7: Medtronic, Inc. Revenues by Geography (2006)
• Figure 8-8: Medtronic, Inc. Revenues by Operating Segments (2006)
• Table 8-23: Partners: Medtronic Navigation
• Table 8-24: Corporate Details of Mentice AB
• Table 8-25: Subsidiaries of Mentice
• Table 8-26: Distributors of Mentice
• Table 8-27: Key Executives: Mentice